Global Contraceptives Market Research Report 2023

The global Contraceptives market was valued at USD 1911.9 million in 2022 and is anticipated to reach USD 2277.4 million by 2029, witnessing a CAGR of 2.5% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

Oral contraceptive pills, implants, injectables, patches, vaginal rings, intrauterine devices, male and female sterilization, lactational amenorrhea techniques, withdrawal, and fertility awareness-based approaches are among the contraceptive methods available. These techniques all work through various mechanisms and are successful in avoiding unwanted pregnancy.

Growing awareness of the importance of family planning and preventing unplanned pregnancies drives market expansion. In addition, rising levels of higher education and increased usage of contraceptives among young women fuel market expansion. The rise in the use of oral tablets as a primary technique to prevent unintended pregnancies as well as health problems related to teenage pregnancies and increased awareness of contemporary contraception all contribute to the expansion of the contraceptives market.

VIEW FULL REPORT
https://reports.valuates.com/reports/QYRE-Auto-8A4479/global-contraceptives

Contraceptive Market Trends
The expansion of the worldwide contraceptive market is fueled by a high absorption rate, an increase in reproductive women's labor force participation, and high population awareness of contraceptive products. The population in developing nations like India, Brazil, Africa, and others has more disposable income, which has led to an increase in the uptake of contraceptive products, fueling the expansion of the worldwide contraceptive market.

During the projection period, it is projected that the introduction of programs aimed at lowering unintended pregnancies and the associated healthcare expenses as well as raising user awareness levels will fuel market growth. Additionally, the rise in unwanted pregnancies is anticipated to aid in the contraceptive market expansion throughout the course of the projected year.

Numerous businesses in the global contraceptives market were compelled to temporarily halt operations because of the COVID-19 pandemic in order to adhere to new laws enacted to stop the disease's spread. The worldwide contraceptives market's revenue flow is directly impacted by this suspension of operations. Additionally, a halt in industrial product production was seen as a result of a shortage of laborers and raw supplies during the COVID-19 epidemic. Furthermore, businesses in this industry did not receive any fresh shipments. As a result, the worldwide contraceptives market was negatively impacted by the suspension of industrial activities and the subsequent lockdowns for several months. During the projection period, the contraceptives market is expected to slowly rebound.

The increase in favorable government initiatives, a rise in population control demands, and the prevalence of unwanted pregnancies will further drive the growth of the contraceptive market.

INQUIRE FOR SAMPLE
https://reports.valuates.com/request/sample/QYRE-Auto-8A4479/Global_Contraceptives_Market_Research_Report_2021

Contrceptives Market By Company
Bayer AG
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
Merck & Co., Inc
Actavis, Inc.
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Sine
Reckitt
AbbVie
The Cooper Companies
TherapeuticsMD
Afaxys
Mithra Pharmaceuticals

Contrceptives Market By Type
Pills
Injectable
Condms
Vaginal Rings
IUDs
Subdermal Implants
Others

Contrceptives Market By End User
15-24 years
25-34 years
35-44 years
Above 44 years

Contrceptives Market By Regional
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina

SIMILAR REPORT

https://reports.valuates.com/reports/ALLI-Manu-2B70/sexual-wellness

https://reports.valuates.com/market-reports/QYRE-Auto-3P9971/global-contraceptive-drugs

Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.
Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

This release was published on openPR.